Stockholm Preterm Interaction-Based Intervention (SPIBI)
Extreme Prematurity
About this trial
This is an interventional prevention trial for Extreme Prematurity focused on measuring cognitive development, motor development, parent-child interaction, parental mental health, strength-based intervention, prematurity
Eligibility Criteria
Inclusion Criteria:
- extremely premature born babies
- close to discharge from their neonatal intensive care unit hospital stay at Stockholm county council (Stockholms Läns Landsting).
Exclusion Criteria:
- Children with parent/parents who do not communicate in Swedish or English.
- Patients not residing in Stockholm county.
- Acute surgery patients who will spend a lot of time at hospitals far from Stockholm
Sites / Locations
- Karolinska Hospital, Danderyds Sjukhus neonatalavdelning
- Karolinska Hospital Huddinge, neontalavdelningen
- Karolinska Hospital
- Stockholm University
- Södersjukhusets neonatalavdelning
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Stockholm Preterm Interaction-Based Intervention (SPIBI)
Control
Home-based post-discharge intervention for extreme premature babies and their parents. The intervention consists of one hospital visit, nine home-visits and two telephone calls during the first year corrected age, specifically from one week before discharge to 12 months corrected age. The intervention is strengths-based working with the infant-parent interaction, supporting infant development and strengthening the parent in his/her role.
The participants of the Control Group receives treatment as usual, which consists of a regular follow-up program with neurodevelopmental assessment at term age, 3 months corrected age, 12 months corrected age, 24 months corrected age and 66 months corrected age. Compared to children not participating in the study, the control group will receive an extended follow-up program, with assessment and questionnaires at term age, 3 months corrected age, 12 months corrected age, 24 months corrected age and 36 months corrected age. Participants in the control group will be referred to specialized care when needed.